おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Geneception
company
About
Geneception is a company focused on the development of breakthrough in gene and cell therapies that are fully-integrated.
- 11 - 50
Highlights
Details
- Last Funding Type
- Series A
- Industries
- Biotechnology
- Founded date
- Jan 1, 2018
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
—
Geneception has raised a total of
—
in funding over 2 rounds. Their latest funding was raised on
Jan 1, 2019 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 1, 2019 | Series A | — | 2 | — | — | Detail |
| Jan 1, 2018 | Seed | — | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Geneception is funded by 2 investors.
ARCH Venture Partners
and Lilly Asia Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
ARCH Venture Partners
|
— | Series A |
Lilly Asia Ventures
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
